Welcome to our dedicated page for Cresud SA news (Ticker: $CRESY), a resource for investors and traders seeking the latest updates and insights on Cresud SA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cresud SA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cresud SA's position in the market.
CRESUD S.A.C.I.F. y A. reported a net loss of ARS 25,646 million for the 9-month period ending March 31, 2024, due to inflation impact on investment properties. However, the adjusted EBITDA increased by 61.4% compared to 2023. The company approved a cash dividend of ARS 30,000 million. Brasilagro sold a fraction of its establishment, generating BRL 365.4 million in gains. The business outlook for 2024 includes better prospects in Argentina's agribusiness.